BL0006
/ Shanghai Best-Link Biosci
- LARVOL DELTA
Home
Next
Prev
1 to 1
Of
1
Go to page
1
February 08, 2024
A Phase I Study to Assess the Safety and Tolerability of BL0006 for Patients With Advanced Solid Tumours
(clinicaltrials.gov)
- P1 | N=66 | Recruiting | Sponsor: Shanghai Best-Link Bioscience, LLC
New P1 trial • Oncology • Solid Tumor
1 to 1
Of
1
Go to page
1